Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00650442 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System
A Phase 1 study, sponsored by Mylan Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT00650442 is a Phase 1 study that has completed, run by Mylan Pharmaceuticals. The registered enrollment target is 39 participants.
The verdict
NCT00650442, a Phase 1 study, has completed, sponsored by Mylan Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
The primary objective of this study was to compare the adhesive quality of the current Mylan estradiol placebo transdermal system, with that of an alternate second generation Mylan estradiol placebo transdermal system following a single system application. As a secondary objective, primary dermal irritation was assessed after removal of each transdermal system.
Interventions
- DRUG Estradiol Transdermal System Placebo - Alternate Adhesive
- DRUG Estradiol Transdermal System Placebo - Current Adhesive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2003-01 |
| Est. Completion | 2003-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00650442
The ClinicalTrials.gov registry entry for NCT00650442 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mylan Pharmaceuticals, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Estradiol Transdermal System Placebo - Alternate Adhesive is the first listed.
NCT00650442 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00650442 about?
NCT00650442 is a clinical study titled "Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System". The primary objective of this study was to compare the adhesive quality of the current Mylan estradiol placebo transdermal system, with that of an alternate second generation Mylan estradiol placebo transdermal system following a single system application. As a secondary objective, primary dermal ir...
What is the current status of trial NCT00650442?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2003-01. Estimated completion is 2003-02.
What interventions are being tested in trial NCT00650442?
The interventions under investigation include: Estradiol Transdermal System Placebo - Alternate Adhesive (DRUG), Estradiol Transdermal System Placebo - Current Adhesive (DRUG).
Who is sponsoring clinical trial NCT00650442?
This trial is sponsored by Mylan Pharmaceuticals, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.